SCHEMBL2544901

SCHEMBL2544901

CS(=O)(=O)OCC(=O)c1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 1/20 0.47
FEN1 P39748 1/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
ALDH1A1 P00352 5/20 0.45
MAPT P10636 2/20 0.45
RAB9A P51151 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
CXCR3 P49682 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 2/20 0.42
NPC1 O15118 2/20 0.41
HSP90AA1 P07900 1/20 0.40
PAX8 Q06710 1/20 0.40
HPGD P15428 1/20 0.40
TP53 P04637 1/20 0.40
RCE1 Q9Y256 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2542705 0.79 KMT2A (0.47) ERCC5FEN1ALDH1A1RAB9AKMT2A
SCHEMBL27208789 0.79 ERCC5 (0.53) ERCC5FEN1CES2CES1ALDH1A1
SCHEMBL5702466 0.79 LMNA (0.43) ALDH1A1MAPTRAB9ASMN1; SMN2KMT2A
SCHEMBL2543077 0.79 L3MBTL1 (0.56) ALDH1A1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL10906907 0.77 ERCC5 (0.51) ERCC5FEN1CES2CES1ALDH1A1
SCHEMBL4637854 0.76 LMNA (0.53) ERCC5FEN1CES2CES1ALDH1A1
SCHEMBL2540632 0.75 NPC1 (0.50) CES1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL27759983 0.74 ERCC5 (0.51) ERCC5FEN1CES2CES1ALDH1A1
SCHEMBL4637996 0.73 NPC1 (0.56) ERCC5FEN1CES2CES1ALDH1A1
SCHEMBL27755244 0.73 ERCC5 (0.47) ERCC5FEN1CES2CES1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044245-B2 Method for the preparation of optically active 2-sulfonyloxy-1-phenylethanol derivatives KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-10-25 US disclosed
US-20100063317-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-03-11 US disclosed
WO-2008054155-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063317-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES FOXO1, ENO1, SULT1A1 ERCC5 4005/4885FEN1 3800/4885CES2 96/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.